Revenio Group Oyj (FRA:R0V)

Market Cap	393.23M -40.2%
Revenue (ttm)	111.05M +4.4%
Net Income	15.71M -17.7%
EPS	0.59 -17.7%
Shares Out	n/a
PE Ratio	25.03
Forward PE	17.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	14.64
Previous Close	14.76
Day's Range	14.64 - 14.64
52-Week Range	11.76 - 24.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 8, 2026

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used by vet...

• Industry: Computer Integrated Systems Design
• Founded: 2001
• Employees: 246
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: R0V

Financial Performance

In 2025, Revenio Group Oyj's revenue was 109.85 million, an increase of 5.80% compared to the previous year's 103.82 million. Earnings were 17.41 million, a decrease of -5.87%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error